Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer
Supportive Care in Cancer · 2023-10 · 31 (10)
DOI: 10.1007/s00520-023-08040-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 20.09.2023. Verfasst von Tamara L Jones und 6 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia. tamara.jones1@unimelb.edu.au. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne.
Abstract (Originalsprache)
Purpose
The purpose of this analysis was to explore associations between exercise behaviour among breast cancer survivors and three behavioural constructs from distinct theories: self-efficacy from social cognitive theory, motivation from self-determination theory, and habits from habit theory.
Methods
Breast cancer survivors ( n = 204) completed a cross-sectional survey that collected demographic and disease characteristics, exercise levels, and self-efficacy, motivation, and habits. Multivariable linear regression models were used to identify constructs associated with total activity and resistance training.
Results
Participants were a mean (SD) age of 57.3 (10.8) years and most were diagnosed with early-stage disease (72%) and engaged in sufficient levels of total activity (94%), though only 45% completed ≥ 2 resistance training sessions/week. Identified motivation ( ꞵ [95% CI] = 7.6 [3.9–11.3]) and habits ( ꞵ [95% CI] = 4.4 [1.4–7.4]) were significantly associated with total activity (as were body mass index and disease stage), whilst identified motivation ( ꞵ [95% CI] = 0.6 [0.3–0.9]) and coping self-efficacy ( ꞵ [95% CI] = 0.02 [< 0.01–0.03]) were significantly associated with resistance training. The models explained 27% and 16% of variance in total activity and resistance training behaviour, respectively.
Conclusion
Results suggest that incorporating strategies that support identified motivation, habits, and coping self-efficacy in future interventions could promote increased exercise behaviour among breast cancer populations. Future longitudinal research should examine associations with exercise in a more representative, population-based sample.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia. tamara.jones1@unimelb.edu.au.
- Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
- Department of Health Services Research, The Peter MacCallum Cancer Centre, Melbourne, Australia.
- Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia.
- Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
- School of Health Sciences and Social Work, Griffith University, Brisbane, Australia.
Förderung
- University of Melbourne
Zitieren
APA
Jones, T. L., Edbrooke, L., Rawstorn, J. C., Hayes, S. C., Maddison, R., Denehy, L., & Short, C. E. (2023). Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer. Supportive Care in Cancer, 31(10). https://doi.org/10.1007/s00520-023-08040-7
Vancouver
Jones TL, Edbrooke L, Rawstorn JC, Hayes SC, Maddison R, Denehy L, et al. Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer. Supportive Care in Cancer. 2023;31(10). doi:10.1007/s00520-023-08040-7
BibTeX
@article{Jones2023,
author = {Jones, Tamara L and Edbrooke, Lara and Rawstorn, Jonathan C and Hayes, Sandra C and Maddison, Ralph and Denehy, Linda and Short, Camille E},
title = {Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer},
journal = {Supportive Care in Cancer},
year = {2023},
volume = {31},
number = {10},
doi = {10.1007/s00520-023-08040-7}
}
EUVIMED